Andrew Kamholz

Andrew Kamholz is an accomplished professional with extensive experience in the fields of bioengineering and microfluidics. Currently serving as the CEO and a member of the Board of Directors at Edge Precision Manufacturing since May 2018, Andrew has been instrumental in leading this company, which is now a subsidiary of ZEON Specialty Materials, Inc. Additionally, Andrew acts as a Scientific and Strategic Advisor at StataDX. Prior roles include Interim CEO at Weavr Health and President of Edge Embossing LLC, a company founded in 2005 specializing in microstructured plastic parts. Andrew's career also features significant contributions as the Director of Advanced Development at Tecan Boston and as a Senior Scientist at MesoSystems Technology. Academic credentials include a PhD in Bioengineering from the University of Washington and a BS in Biomedical Engineering from The Johns Hopkins University, supplemented by registration as a Patent Agent.